This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Creatine kinase

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Creatine kinase is an widespread enzyme catalyzing the phosphorylation of creatine to creatine phosphate. It occurs as three different isoenzymes, each composed of two polypeptide chains, B and M:

  • skeletal muscle has a very high CK content; usually, 98% CK-MM and 2% CK-MB
  • cardiac muscle also has a very high CK content; usually, 70-80% CK-MM and 20-30% CK-MB
  • brain, prostate, thyroid, gut and lung has predominantly CK-BB
  • plasma has predominantly CK-MM with less than 6% CK-MB

Usually, the heart is the only tissue in which the amount of CK-MB exceeds 5%. Exceptions are patients with muscle disease and in athletes, in which the skeletal muscle content of CK-MB may rise to 5-15%.

Normally the laboratory provides total CK levels. Normal ranges are 24-170 Units/litre in women, 24-195 in men. A heparinised plasma is required.

The clinician must be aware of the the rare false positives provided by macro CK-1 and macro CK-2.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.